These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 26304974)

  • 21. Reacting to prognostic covariate imbalance in randomised controlled trials.
    Coskinas X; Schou IM; Simes J; Martin A
    Contemp Clin Trials; 2021 Nov; 110():106544. PubMed ID: 34454099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles and procedures for data and safety monitoring in pragmatic clinical trials.
    Simon GE; Shortreed SM; Rossom RC; Penfold RB; Sperl-Hillen JAM; O'Connor P
    Trials; 2019 Dec; 20(1):690. PubMed ID: 31815644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Opportunities and Challenges of Pragmatic Randomized Trials Using a Specialized Software: CloudTrials Project.
    Fosser SM; Kamozin A; McDonald EG; Tamblyn R; Lee TC
    Stud Health Technol Inform; 2019 Aug; 264():1544-1545. PubMed ID: 31438223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Series: Pragmatic trials and real world evidence: Paper 7. Safety, quality and monitoring.
    Irving E; van den Bor R; Welsing P; Walsh V; Alfonso-Cristancho R; Harvey C; Garman N; Grobbee DE;
    J Clin Epidemiol; 2017 Nov; 91():6-12. PubMed ID: 28502812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling multilevel nonlinear treatment-by-covariate interactions in cluster randomized controlled trials using a generalized additive mixed model.
    Cho SJ; Preacher KJ; Yaremych HE; Naveiras M; Fuchs D; Fuchs LS
    Br J Math Stat Psychol; 2022 Nov; 75(3):493-521. PubMed ID: 35312188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pragmatic Trials in Maintenance Dialysis: Perspectives from the Kidney Health Initiative.
    Dember LM; Archdeacon P; Krishnan M; Lacson E; Ling SM; Roy-Chaudhury P; Smith KA; Flessner MF
    J Am Soc Nephrol; 2016 Oct; 27(10):2955-2963. PubMed ID: 27401689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Series: Pragmatic trials and real world evidence: Paper 8. Data collection and management.
    Meinecke AK; Welsing P; Kafatos G; Burke D; Trelle S; Kubin M; Nachbaur G; Egger M; Zuidgeest M;
    J Clin Epidemiol; 2017 Nov; 91():13-22. PubMed ID: 28716504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Method of Randomization for Cluster-Randomized Trials: Challenges of Including Patients with Multiple Chronic Conditions.
    Esserman D; Allore HG; Travison TG
    Int J Stat Med Res; 2016 Jan; 5(1):2-7. PubMed ID: 27478520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research-grade data in the real world: challenges and opportunities in data quality from a pragmatic trial in community-based practices.
    Divney AA; Lopez PM; Huang TT; Thorpe LE; Trinh-Shevrin C; Islam NS
    J Am Med Inform Assoc; 2019 Aug; 26(8-9):847-854. PubMed ID: 31181144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nonlinear mixed-effects modeling approach for ecological data: Using temporal dynamics of vegetation moisture as an example.
    Oddi FJ; Miguez FE; Ghermandi L; Bianchi LO; Garibaldi LA
    Ecol Evol; 2019 Sep; 9(18):10225-10240. PubMed ID: 31624547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pragmatic trials are important to medical research].
    Bjerre E; Brasso K; Midtgaard J
    Ugeskr Laeger; 2015 Jul; 177(31):. PubMed ID: 26238009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Key considerations for choosing a statistical method to deal with incomplete treatment adherence in pragmatic trials.
    Hossain MB; Karim ME
    Pharm Stat; 2023 Jan; 22(1):205-231. PubMed ID: 36637242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Trials: Spline Modeling is Wonderful for Nonlinear Effects.
    Cleophas TJ
    Am J Ther; 2016; 23(3):e844-9. PubMed ID: 23689089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical methods in randomised controlled trials for delirium.
    Farewell D; Tahir TA; Bisson J
    J Psychosom Res; 2012 Sep; 73(3):197-204. PubMed ID: 22850260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyzing preventive trials with generalized additive models.
    Brown CH
    Am J Community Psychol; 1993 Oct; 21(5):635-64. PubMed ID: 8192125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deriving Real-World Insights From Real-World Data: Biostatistics to the Rescue.
    Pencina MJ; Rockhold FW; D'Agostino RB
    Ann Intern Med; 2018 Sep; 169(6):401-402. PubMed ID: 30039173
    [No Abstract]   [Full Text] [Related]  

  • 37. Adding value to real-world data: the role of biomarkers.
    Plant D; Barton A
    Rheumatology (Oxford); 2020 Jan; 59(1):31-38. PubMed ID: 31329972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of multisite intervention studies using generalized linear mixed models.
    White NM; Barnett AG
    Infect Control Hosp Epidemiol; 2019 Aug; 40(8):910-917. PubMed ID: 31223101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imbalance in the health workforce.
    Zurn P; Dal Poz MR; Stilwell B; Adams O
    Hum Resour Health; 2004 Sep; 2(1):13. PubMed ID: 15377382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pragmatic trials of complex psychosocial interventions: methodological challenges.
    Dunn G
    Epidemiol Psychiatr Sci; 2013 Jun; 22(2):105-9. PubMed ID: 23458721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.